Nazila Habibizad Net Worth & Insider Trades

Nazila Habibizad - See Remarks, Global Blood Therapeutics, Inc

As of October 6, 2022

What is Nazila Habibizad's Net Worth?

The current estimated net worth of Global Blood Therapeutics, Inc's See Remarks, Nazila Habibizad, is estimated to be about $1.02M . Nazila Habibizad owns about 8,918 units of Global Blood Therapeutics, Inc common stock. In the last 8 months at Global Blood Therapeutics, Inc, Nazila Habibizad has sold an estimated value of $460.52K worth.

What is Nazila Habibizad's Past Insider Trading?

Nazila Habibizad's largest sale order was 4,678 units , worth over $314.31K on August 19, 2022. In total, Nazila Habibizad has made about 8 transactions over 8 months of their time at Global Blood Therapeutics, Inc. Nazila Habibizad usually trades in August, October and September, with the busiest year in 2022.

Nazila Habibizad

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Nazila Habibizad's' Mailing Address?

  • Mailing address is C/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd South San Francisco CA 94080 CA

Global Blood Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ted Love, M.D. 2020 $661,250 - $11,778,840 $4,693,666 $467,000 $5,000 $17,605,756
Ted Love, M.D. 2019 $596,876 - $4,359,600 $4,595,717 $540,000 $5,000 $10,097,193
Ted Love, M.D. 2018 $568,750 - $4,648,800 $4,623,690 $414,000 $5,000 $10,260,240
David Johnson 2020 $463,750 - $4,037,361 $1,582,504 $234,000 $5,000 $6,322,615
David Johnson 2019 $453,125 - $1,211,000 $1,267,784 $250,000 $5,000 $3,186,909
David Johnson 2018 $355,000 $75,000 $1,897,750 $1,898,534 $169,000 $5,000 $4,394,284
Jeffrey Farrow 2020 $457,813 - $3,708,261 $1,582,504 $231,500 $5,000 $5,985,078
Jeffrey Farrow 2019 $440,625 - $1,211,000 $1,267,784 $244,000 $5,000 $3,168,409
Jeffrey Farrow 2018 $425,938 - $1,370,800 $1,326,469 $201,000 $5,000 $3,329,207
Jung Choi 2020 $433,125 - $3,708,261 $1,582,504 $219,000 $5,000 $5,947,890
Jung Choi 2019 $416,875 - $1,211,000 $1,267,784 $231,000 $5,000 $3,131,659
Jung Choi 2018 $392,063 - $1,370,800 $1,326,469 $185,000 $5,000 $3,279,332
Tricia Suvari 2020 $422,499 - $3,708,261 $1,582,504 $214,000 $5,000 $5,932,264
Tricia Suvari 2019 $403,125 - $1,211,000 $1,267,784 $223,000 $5,000 $3,109,909
Tricia Suvari 2018 $386,875 - $1,549,600 $1,515,964 $183,000 $5,000 $3,640,439
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm

What are Global Blood Therapeutics, Inc's Past Insider Trades?

Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks,  Ted Love, President and CEO,  and Borga Tricia Suvari, Chief Legal Officer .

Global Blood Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1